{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,13]],"date-time":"2026-09-13T03:16:47Z","timestamp":1789269407303,"version":"build-2803163510"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T00:00:00Z","timestamp":1760054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T00:00:00Z","timestamp":1760054400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82204660"],"award-info":[{"award-number":["82204660"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["52473152"],"award-info":[{"award-number":["52473152"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the \"Pioneer\" and \"Leading Goose\" R&D Program of Zhejiang","award":["2025C02132"],"award-info":[{"award-number":["2025C02132"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"DOI":"10.1186\/s12951-025-03737-9","type":"journal-article","created":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T12:25:49Z","timestamp":1760099149000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Fe-MOF loaded with capmatinib to reverse immunosuppressive microenvironment and inhibit tumor metastasis after radiofrequency ablation"],"prefix":"10.1186","volume":"23","author":[{"given":"Jinchao","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianfei","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junkang","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenbin","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angfeng","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaomin","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiao","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,10]]},"reference":[{"key":"3737_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel R, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229\u201363.","journal-title":"CA Cancer J Clin"},{"key":"3737_CR2","doi-asserted-by":"publisher","first-page":"6082","DOI":"10.1039\/D4BM01190B","volume":"12","author":"J Zhao","year":"2024","unstructured":"Zhao J, Lei L, Dai W, Jiang A, Jin Q, Tang T. Simultaneous inhibition of heat shock proteins and autophagy enhances radiofrequency ablation of hepatocellular carcinoma. Biomater Sci. 2024;12:6082\u201398.","journal-title":"Biomater Sci"},{"key":"3737_CR3","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.202302013","volume":"12","author":"Y Tang","year":"2023","unstructured":"Tang Y, Shu Z, Zhu M, Li S, Ling Y, Fu Y, et al. Size-tunable nanoregulator-based radiofrequency ablation suppresses MDSCs and their compensatory immune evasion in hepatocellular carcinoma. Adv Healthc Mater. 2023;12:e2302013.","journal-title":"Adv Healthc Mater"},{"issue":"6","key":"3737_CR4","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1016\/j.ymthe.2022.08.004","volume":"31","author":"S Zhu","year":"2023","unstructured":"Zhu S, Wu Y, Zhang X, Peng S, Xiao H, Chen S, et al. Targeting N7-methylguanosine tRNA modification blocks hepatocellular carcinoma metastasis after insufficient radiofrequency ablation. Mol Ther. 2023;31(6):1596\u2013614.","journal-title":"Mol Ther"},{"key":"3737_CR5","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1016\/S0140-6736(22)01200-4","volume":"400","author":"A Vogel","year":"2022","unstructured":"Vogel A, Meyer T, Sapisochin G, Salem R, Saborowski A. Hepatocellular carcinoma. Lancet. 2022;400:1345\u201362.","journal-title":"Lancet"},{"key":"3737_CR6","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.jconrel.2024.01.048","volume":"369","author":"F Ao","year":"2024","unstructured":"Ao F, Li X, Tan Y, Jiang Z, Yang F, Guo J, et al. Sting agonist-based hydrogel enhances immune activation in synergy with radiofrequency ablation for hepatocellular carcinoma treatment. J Control Release. 2024;369:296\u2013308.","journal-title":"J Control Release"},{"key":"3737_CR7","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1016\/S1470-2045(04)01567-0","volume":"5","author":"B Decadt","year":"2004","unstructured":"Decadt B, Siriwardena A. Radiofrequency ablation of liver tumours: systematic review. Lancet Oncol. 2004;5:550\u201360.","journal-title":"Lancet Oncol"},{"key":"3737_CR8","doi-asserted-by":"publisher","first-page":"4594","DOI":"10.1158\/0008-5472.CAN-21-1040","volume":"81","author":"X Kan","year":"2021","unstructured":"Kan X, Zhou G, Zhang F, Ji H, Zheng H, Chick J, et al. Interventional optical imaging permits instant visualization of pathological zones of ablated tumor periphery and residual tumor detection. Cancer Res. 2021;81:4594\u2013602.","journal-title":"Cancer Res"},{"key":"3737_CR9","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1002\/hep.31766","volume":"74","author":"T Su","year":"2021","unstructured":"Su T, Huang M, Liao J, Lin S, Yu P, Yang J, et al. Insufficient radiofrequency ablation promotes hepatocellular carcinoma metastasis through N6-methyladenosine mRNA methylation-dependent mechanism. Hepatology. 2021;74:1339\u201356.","journal-title":"Hepatology"},{"key":"3737_CR10","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.canlet.2015.09.020","volume":"370","author":"L Chen","year":"2016","unstructured":"Chen L, Sun J, Yang X. Radiofrequency ablation-combined multimodel therapies for hepatocellular carcinoma: current status. Cancer Lett. 2016;370:78\u201384.","journal-title":"Cancer Lett"},{"key":"3737_CR11","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1186\/s12951-023-02067-y","volume":"21","author":"S Zhang","year":"2023","unstructured":"Zhang S, Huang Y, Pi S, Chen H, Ye F, Wu C, et al. Autophagy-amplifying nanoparticles evoke immunogenic cell death combined with anti-PD-1\/PD-L1 for residual tumors immunotherapy after RFA. J Nanobiotechnol. 2023;21:360.","journal-title":"J Nanobiotechnol"},{"key":"3737_CR12","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s12951-024-02989-1","volume":"23","author":"M Yang","year":"2025","unstructured":"Yang M, Liu D, Tan Y, Chen J, Yang F, Mei C, et al. Polyoxometalate-based injectable coacervate inhibits HCC metastasis after incomplete radiofrequency ablation via scavenging ROS. J Nanobiotechnol. 2025;23:47.","journal-title":"J Nanobiotechnol"},{"key":"3737_CR13","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s10495-024-02019-3","volume":"30","author":"J Liang","year":"2024","unstructured":"Liang J, Ma M, Feng W, Xu Q, Chen D, Lai J, et al. Anti-PD-L1 blockade facilitates antitumor effects of radiofrequency ablation by improving tumor immune microenvironment in hepatocellular carcinoma. Apoptosis. 2024;30:55\u201368.","journal-title":"Apoptosis"},{"key":"3737_CR14","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1007\/s00432-024-05996-9","volume":"150","author":"B Xiong","year":"2024","unstructured":"Xiong B, Li C, Hong G, Li J, Luo Q, Gong J, et al. HMGB1\/TREM1 crosstalk between heat-injured hepatocytes and macrophages promotes HCC progression after RFA. J Cancer Res Clin Oncol. 2024;150:480.","journal-title":"J Cancer Res Clin Oncol"},{"key":"3737_CR15","doi-asserted-by":"publisher","first-page":"122456","DOI":"10.1016\/j.biomaterials.2023.122456","volume":"305","author":"S Chen","year":"2024","unstructured":"Chen S, Ma T, Wang J, Liang S, Liao H, Tan W, et al. Macrophage-derived biomimetic nanoparticles enhanced SDT combined with immunotherapy inhibited tumor growth and metastasis. Biomaterials. 2024;305:122456.","journal-title":"Biomaterials"},{"key":"3737_CR16","doi-asserted-by":"publisher","first-page":"4231","DOI":"10.1021\/acs.nanolett.1c00209","volume":"21","author":"B Wei","year":"2021","unstructured":"Wei B, Pan J, Yuan R, Shao B, Wang Y, Guo X, et al. Polarization of tumor-associated macrophages by nanoparticle-loaded Escherichia coli combined with immunogenic cell death for cancer immunotherapy. Nano Lett. 2021;21:4231\u201340.","journal-title":"Nano Lett"},{"key":"3737_CR17","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1038\/s41423-018-0184-y","volume":"16","author":"A Xu","year":"2019","unstructured":"Xu A, Zhang L, Yuan J, Babikr F, Freywald A, Chibbar R, et al. TLR9 agonist enhances radiofrequency ablation-induced CTL responses, leading to the potent inhibition of primary tumor growth and lung metastasis. Cell Mol Immunol. 2019;16:820\u201332.","journal-title":"Cell Mol Immunol"},{"key":"3737_CR18","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1186\/s12943-022-01681-y","volume":"21","author":"Y Sun","year":"2022","unstructured":"Sun Y, Yang J, Li Y, Luo J, Sun J, Li D, et al. Single low-dose INC280-loaded theranostic nanoparticles achieve multirooted delivery for MET-targeted primary and liver metastatic NSCLC. Mol Cancer. 2022;21:212.","journal-title":"Mol Cancer"},{"key":"3737_CR19","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1186\/s13046-022-02475-2","volume":"41","author":"T Zhang","year":"2022","unstructured":"Zhang T, Wang Y, Xie M, Ji X, Luo X, Chen X, et al. HGF-mediated elevation of ETV1 facilitates hepatocellular carcinoma metastasis through upregulating PTK2 and c-MET. J Exp Clin Cancer Res. 2022;41:275.","journal-title":"J Exp Clin Cancer Res"},{"key":"3737_CR20","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1002\/hep.29496","volume":"67","author":"M Bouattour","year":"2018","unstructured":"Bouattour M, Raymond E, Qin S, Cheng A, Stammberger U, Locatelli G, et al. Recent developments of c-Met as a therapeutic target in hepatocellular carcinoma. Hepatology. 2018;67:1132\u201349.","journal-title":"Hepatology"},{"key":"3737_CR21","doi-asserted-by":"publisher","first-page":"7279","DOI":"10.1038\/s41388-020-01500-y","volume":"39","author":"Q He","year":"2020","unstructured":"He Q, Lin Z, Wang Z, Huang W, Tian D, Liu M, et al. SIX4 promotes hepatocellular carcinoma metastasis through upregulating YAP1 and c-MET. Oncogene. 2020;39:7279\u201395.","journal-title":"Oncogene"},{"key":"3737_CR22","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1148\/radiol.2015150080","volume":"279","author":"M Ahmed","year":"2016","unstructured":"Ahmed M, Kumar G, Moussa M, Wang Y, Rozenblum N, Galun E, et al. Hepatic radiofrequency ablation-induced stimulation of distant tumor growth is suppressed by c-Met inhibition. Radiology. 2016;279:103\u201317.","journal-title":"Radiology"},{"key":"3737_CR23","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1148\/radiol.2017162943","volume":"286","author":"G Kumar","year":"2018","unstructured":"Kumar G, Goldberg S, Gourevitch S, Levchenko T, Torchilin V, Galun E, et al. Targeting STAT3 to suppress systemic pro-oncogenic effects from hepatic radiofrequency ablation. Radiology. 2018;286:524\u201336.","journal-title":"Radiology"},{"key":"3737_CR24","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1148\/radiol.2019191023","volume":"294","author":"H Liao","year":"2020","unstructured":"Liao H, Ahmed M, Markezana A, Zeng G, Stechele M, Galun E, et al. Thermal ablation induces transitory metastatic growth by means of the STAT3\/c-Met molecular pathway in an intrahepatic colorectal cancer mouse model. Radiology. 2020;294:464\u201372.","journal-title":"Radiology"},{"key":"3737_CR25","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1158\/1078-0432.CCR-21-1566","volume":"28","author":"L Mathieu","year":"2022","unstructured":"Mathieu L, Larkins E, Akinboro O, Roy P, Amatya A, Fiero M, et al. FDA approval summary: capmatinib and tepotinib for the treatment of metastatic NSCLC harboring MET exon 14 skipping mutations or alterations. Clin Cancer Res. 2022;28:249\u201354.","journal-title":"Clin Cancer Res"},{"key":"3737_CR26","doi-asserted-by":"publisher","first-page":"e2306203","DOI":"10.1002\/advs.202306203","volume":"11","author":"L Xu","year":"2024","unstructured":"Xu L, Peng M, Gao T, Wang D, Lian X, Sun H, et al. Nanoenabled intracellular metal ion homeostasis regulation for tumor therapy. Adv Sci. 2024;11:e2306203.","journal-title":"Adv Sci"},{"key":"3737_CR27","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202304092","volume":"10","author":"R Qian","year":"2023","unstructured":"Qian R, Yi X, Liu T, Chen H, Wang Y, Hu L, et al. Regulation of ion homeostasis for enhanced tumor radio-immunotherapy. Adv Sci. 2023;10:e2304092.","journal-title":"Adv Sci"},{"key":"3737_CR28","doi-asserted-by":"publisher","first-page":"5670","DOI":"10.1021\/jacs.8b01072","volume":"140","author":"G Lan","year":"2018","unstructured":"Lan G, Ni K, Xu Z, Veroneau S, Song Y, Lin W. Nanoscale metal-organic framework overcomes hypoxia for photodynamic therapy primed cancer immunotherapy. J Am Chem Soc. 2018;140:5670\u20133.","journal-title":"J Am Chem Soc"},{"key":"3737_CR29","doi-asserted-by":"publisher","DOI":"10.1002\/smll.202001343","volume":"16","author":"T Jia","year":"2020","unstructured":"Jia T, Wang Z, Sun Q, Dong S, Xu J, Zhang F, et al. Intelligent Fe-Mn layered double hydroxides nanosheets anchored with upconversion nanoparticles for oxygen-elevated synergetic therapy and bioimaging. Small. 2020;16:e2001343.","journal-title":"Small"},{"key":"3737_CR30","doi-asserted-by":"publisher","DOI":"10.1002\/smll.202103919","volume":"17","author":"L Zhou","year":"2021","unstructured":"Zhou L, Chen J, Li R, Wei L, Xiong H, Wang C, et al. Metal-polyphenol-network coated Prussian blue nanoparticles for synergistic ferroptosis and apoptosis via triggered GPX4 inhibition and concurrent in situ bleomycin toxification. Small. 2021;17:e2103919.","journal-title":"Small"},{"key":"3737_CR31","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202304407","volume":"10","author":"B Xie","year":"2023","unstructured":"Xie B, Zhao H, Ding Y, Wang Z, Gao C, Li S, et al. Supramolecularly engineered conjugate of bacteria and cell membrane-coated magnetic nanoparticles for enhanced ferroptosis and immunotherapy of tumors. Adv Sci. 2023;10:e2304407.","journal-title":"Adv Sci"},{"key":"3737_CR32","doi-asserted-by":"publisher","first-page":"56634","DOI":"10.1021\/acsami.4c10036","volume":"16","author":"Y Li","year":"2024","unstructured":"Li Y, Li M, Zheng J, Ma Z, Yu T, Zhu Y, et al. Ultrasound-responsive nanocarriers delivering siRNA and Fe3O4 nanoparticles reprogram macrophages and inhibit M2 polarization for enhanced NSCLC immunotherapy. ACS Appl Mater Interfaces. 2024;16:56634\u201352.","journal-title":"ACS Appl Mater Interfaces"},{"key":"3737_CR33","doi-asserted-by":"publisher","first-page":"e2003543","DOI":"10.1002\/smll.202003543","volume":"16","author":"L Liu","year":"2020","unstructured":"Liu L, Wang Y, Guo X, Zhao J, Zhou S. A biomimetic polymer magnetic nanocarrier polarizing tumor-associated macrophages for potentiating immunotherapy. Small. 2020;16:e2003543.","journal-title":"Small"},{"key":"3737_CR34","doi-asserted-by":"publisher","first-page":"122392","DOI":"10.1016\/j.biomaterials.2023.122392","volume":"303","author":"Z Qiu","year":"2023","unstructured":"Qiu Z, Lu Z, Huang J, Zhong Y, Yan N, Kong R, et al. Self-reinforced photodynamic immunostimulator to downregulate and block PD-L1 for metastatic breast cancer treatment. Biomaterials. 2023;303:122392.","journal-title":"Biomaterials"},{"key":"3737_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2024.216964","volume":"593","author":"Y Yu","year":"2024","unstructured":"Yu Y, Liang Y, Xie F, Zhang Z, Zhang P, Zhao X, et al. Tumor-associated macrophage enhances PD-L1-mediated immune escape of bladder cancer through PKM2 dimer-STAT3 complex nuclear translocation. Cancer Lett. 2024;593:216964.","journal-title":"Cancer Lett"},{"key":"3737_CR36","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202301638","volume":"10","author":"Z Bu","year":"2023","unstructured":"Bu Z, Yang J, Zhang Y, Luo T, Fang C, Liang X, et al. Sequential ubiquitination and phosphorylation epigenetics reshaping by MG132-loaded Fe-MOF disarms treatment resistance to repulse metastatic colorectal cancer. Adv Sci. 2023;10:e2301638.","journal-title":"Adv Sci"},{"key":"3737_CR37","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202303872","volume":"10","author":"Z Zhao","year":"2023","unstructured":"Zhao Z, Wu Y, Liang X, Liu J, Luo Y, Zhang Y, et al. Sonodynamic therapy of NRP2 monoclonal antibody-guided MOFs@COF targeted disruption of mitochondrial and Endoplasmic reticulum homeostasis to induce autophagy-dependent ferroptosis. Adv Sci. 2023;10:e2303872.","journal-title":"Adv Sci"},{"key":"3737_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.cclet.2023.108821","volume":"35","author":"F Wang","year":"2024","unstructured":"Wang F, Yao H, Wu X, Tang Y, Bai Y, Chong H, et al. Metal-organic framework and its composites modulate macrophage polarization in the treatment of inflammatory diseases. Chin Chem Lett. 2024;35:108821.","journal-title":"Chin Chem Lett"},{"key":"3737_CR39","doi-asserted-by":"publisher","first-page":"12261","DOI":"10.1021\/acsnano.4c00844","volume":"18","author":"Z Fan","year":"2024","unstructured":"Fan Z, Wu S, Deng H, Li G, Huang L, Liu H. Light-triggered nanozymes remodel the tumor hypoxic and immunosuppressive microenvironment for ferroptosis-enhanced antitumor immunity. ACS Nano. 2024;18:12261\u201375.","journal-title":"ACS Nano"},{"key":"3737_CR40","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adk3201","volume":"10","author":"K Chen","year":"2024","unstructured":"Chen K, Zhou A, Zhou X, He J, Xu Y, Ning X. Cellular trojan horse initiates bimetallic Fe-Cu MOF-mediated synergistic cuproptosis and ferroptosis against malignancies. Sci Adv. 2024;10:eadk3201.","journal-title":"Sci Adv"},{"key":"3737_CR41","doi-asserted-by":"publisher","first-page":"542","DOI":"10.20892\/j.issn.2095-3941.2018.0407","volume":"16","author":"Z Zhang","year":"2019","unstructured":"Zhang Z, Zhang Y, Zhang L, Pei Y, Wu Y, Liang H, et al. Incomplete radiofrequency ablation provokes colorectal cancer liver metastases through heat shock response by PKCalpha\/Fra-1 pathway. Cancer Biol Med. 2019;16:542\u201355.","journal-title":"Cancer Biol Med"},{"key":"3737_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2021.112910","volume":"409","author":"F Wang","year":"2021","unstructured":"Wang F, Xu C, Li G, Lv P, Gu J. Incomplete radiofrequency ablation induced chemoresistance by up-regulating heat shock protein 70 in hepatocellular carcinoma. Exp Cell Res. 2021;409:112910.","journal-title":"Exp Cell Res"},{"key":"3737_CR43","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.hbpd.2018.09.012","volume":"17","author":"C Yuan","year":"2018","unstructured":"Yuan C, Wang Z, Liu K, Liu D. Incomplete radiofrequency ablation promotes the development of CD133(+) cancer stem cells in hepatocellular carcinoma cell line HepG2 via inducing SOX9 expression. Hepatobiliary Pancreat Dis Int. 2018;17:416\u201322.","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"3737_CR44","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.2147\/JHC.S408800","volume":"10","author":"Q Wei","year":"2023","unstructured":"Wei Q, Liu G, Huang Z, Huang Y, Huang L, Huang Z, et al. LncRNA MEG3 inhibits tumor progression by modulating macrophage phenotypic polarization via miR-145-5p\/DAB2 axis in hepatocellular carcinoma. J Hepatocell Carcino. 2023;10:1019\u201335.","journal-title":"J Hepatocell Carcino"},{"key":"3737_CR45","doi-asserted-by":"publisher","unstructured":"Song M, Yang T, He M, Cao G. Lipopolysaccharide-induced M1-type macrophages enhance T cell activity and promote the apoptosis of hepatocellular carcinoma cells. Curr Top Med Chem. 2025. https:\/\/doi.org\/10.2174\/0115680266394539250707102011.","DOI":"10.2174\/0115680266394539250707102011"},{"key":"3737_CR46","doi-asserted-by":"publisher","first-page":"3919","DOI":"10.3390\/molecules29163919","volume":"29","author":"L Shen","year":"2024","unstructured":"Shen L, Lin Z, Gong R, Lin Y, Qiao X, Hu Q, et al. \u03b2,\u03b2-dimethylacrylalkannin, a natural naphthoquinone, inhibits the growth of hepatocellular carcinoma cells by modulating tumor-associated macrophages. Molecules. 2024;29:3919.","journal-title":"Molecules"},{"key":"3737_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2024.136390","volume":"281","author":"J Song","year":"2024","unstructured":"Song J, Li J, Zhang A, Tan X, Li S, Luo L, et al. Combination of lipopolysaccharide and polygalacturonic acid exerts antitumor activity and augments anti-PD-L1 immunotherapy. Int J Biol Macromol. 2024;281:136390.","journal-title":"Int J Biol Macromol"},{"key":"3737_CR48","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.actbio.2025.01.021","volume":"194","author":"J Li","year":"2025","unstructured":"Li J, Mao K, Meng X, Wang J, Zhao M, Lv Y, et al. Injectable hydrogel-assisted local lipopolysaccharide delivery improves immune checkpoint blockade therapy. Acta Biomater. 2025;194:153\u201368.","journal-title":"Acta Biomater"},{"key":"3737_CR49","first-page":"702","volume":"52","author":"J Gao","year":"2025","unstructured":"Gao J, Ye T, Miao H, Liu M, Wen L, Tian Y, et al. Antibody-functionalized iron-based nanoplatform for ferroptosis-augmented targeted therapy of HER2-positive breast cancer. Bioact Mater. 2025;52:702\u201318.","journal-title":"Bioact Mater"},{"key":"3737_CR50","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2022.1012505","volume":"9","author":"Y Liang","year":"2022","unstructured":"Liang Y, Su S, Lun Z, Zhong Z, Yu W, He G, et al. Ferroptosis regulator SLC7A11 is a prognostic marker and correlated with PD-L1 and immune cell infiltration in liver hepatocellular carcinoma. Front Mol Biosci. 2022;9:1012505.","journal-title":"Front Mol Biosci"},{"key":"3737_CR51","doi-asserted-by":"publisher","first-page":"1323581","DOI":"10.3389\/fimmu.2023.1323581","volume":"14","author":"L Hao","year":"2023","unstructured":"Hao L, Li S, Deng J, Li N, Yu F, Jiang Z, et al. The current status and future of PD-L1 in liver cancer. Front Immunol. 2023;14:1323581.","journal-title":"Front Immunol"},{"key":"3737_CR52","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/s13046-018-0777-4","volume":"37","author":"F Xu","year":"2018","unstructured":"Xu F, Jin T, Zhu Y, Dai C. Immune checkpoint therapy in liver cancer. J Exp Clin Cancer Res. 2018;37:110.","journal-title":"J Exp Clin Cancer Res"},{"key":"3737_CR53","first-page":"120","volume":"9","author":"J Zhan","year":"2022","unstructured":"Zhan J, Wang Y, Ma S, Qin Q, Wang L, Cai Y, et al. Organelle-inspired supramolecular nanomedicine to precisely abolish liver tumor growth and metastasis. Bioact Mater. 2022;9:120\u201333.","journal-title":"Bioact Mater"},{"key":"3737_CR54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.biomaterials.2017.07.030","volume":"143","author":"R Zhao","year":"2017","unstructured":"Zhao R, Li T, Zheng G, Jiang K, Fan L, Shao J. Simultaneous inhibition of growth and metastasis of hepatocellular carcinoma by co-delivery of ursolic acid and Sorafenib using lactobionic acid modified and pH-sensitive chitosan-conjugated mesoporous silica nanocomplex. Biomaterials. 2017;143:1\u201316.","journal-title":"Biomaterials"},{"key":"3737_CR55","doi-asserted-by":"publisher","first-page":"19441","DOI":"10.1021\/acsnano.3c08064","volume":"17","author":"Z Tian","year":"2023","unstructured":"Tian Z, Hu Q, Sun Z, Wang N, He H, Tang Z, et al. A booster for radiofrequency ablation: advanced adjuvant therapy via in situ nanovaccine synergized with anti-programmed death ligand 1 immunotherapy for systemically constraining hepatocellular carcinoma. ACS Nano. 2023;17:19441\u201358.","journal-title":"ACS Nano"},{"key":"3737_CR56","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1186\/s12951-024-02636-9","volume":"22","author":"S Lin","year":"2024","unstructured":"Lin S, Shu L, Guo Y, Yuan J, Zhang J, Wang Y, et al. Cargo-eliminated osteosarcoma-derived small extracellular vesicles mediating competitive cellular uptake for inhibiting pulmonary metastasis of osteosarcoma. J Nanobiotechnol. 2024;22:360.","journal-title":"J Nanobiotechnol"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-025-03737-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-025-03737-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-025-03737-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:05:28Z","timestamp":1760105128000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnanobiotechnology.biomedcentral.com\/articles\/10.1186\/s12951-025-03737-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,10]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3737"],"URL":"https:\/\/doi.org\/10.1186\/s12951-025-03737-9","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,10]]},"assertion":[{"value":"13 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiments were conducted following the guidelines for Institutional Animal Care and Use Committee, Zhejiang Center of Laboratory Animals (IACUC, ZJCLA) and the \u201cPrinciples of Laboratory Animal Care\u201d (NIH publication no.86\u2009\u2212\u200923, revised 1985). The assigned approval number was ZJCLA-IACUC-20010750.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"648"}}